Edward Kim

Walker (United States) — United States

Medicine · Health Sciences

40h-index7.0kcitations291works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(75), Cancer Immunotherapy and Biomarkers(32), Lung Cancer Treatments and Mutations(30), Colorectal Cancer Treatments and Studies(29), Cancer Genomics and Diagnostics(29)

Publications289 total

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix
Journal for ImmunoTherapy of Cancer·2026Open Access
${{\protect\mathcal{H}}_{\infty} }$ Performance Analysis for Almost Periodic Piecewise Linear Systems With Application to Roll-to-Roll Manufacturing Control
IEEE/ASME Transactions on Mechatronics·2026Open Access
${{\protect\mathcal{H}}_{\infty} }$ Performance Analysis for Almost Periodic Piecewise Linear Systems With Application to Roll-to-Roll Manufacturing Control
IEEE/ASME Transactions on Mechatronics·2026
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced <i>TP53</i> mutant gastroesophageal cancer
The Oncologist·2025Open Access
268 Regional B7-H3 CAR cell therapy and liver-directed radiation for pancreatic cancer liver metastases
Regular and Young Investigator Award Abstracts·2025Open Access
705 Immunosuppressive CD14 <sup>+</sup> monocytes are enriched in patients with hepatocellular carcinoma and worse liver function (child-pugh B) and are associated with unfavorable immunotherapy outcomes
Regular and Young Investigator Award Abstracts·2025Open Access
Phase 1 clinical trial of the ataxia telangiectasia and Rad3‐related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
Cancer·2025
Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium
JCO Precision Oncology·2025
Abstract A074: A novel nano-formulated taxoid (RP-001) enhances T-cell infiltration and prolongs survival in preclinical models of pancreatic ductal adenocarcinoma
Cancer Research·2025
Experience of patients with HIV and squamous cell carcinoma of the anal canal (SCAC) treated with retifanlimab.
Journal of Clinical Oncology·2025
Quantitative CT and Machine Learning-derived Hyper- and Hypo- Functional Regions Associate Heterogeneous Ventilation and Reduced Deformation With PFT and Smoking in COPD
American Journal of Respiratory and Critical Care Medicine·2025
30- and 90-day Rehospitalization Rates for Patients With Pulmonary Embolism Complicated by Pulmonary Infarction
American Journal of Respiratory and Critical Care Medicine·2025· 1 cited
Abstract No. 541 Adjuvant Immunotherapy After Transarterial Radioembolization in Patients with High-Risk Hepatocellular Carcinoma: A Single-Center, Single-Arm Retrospective Study
Journal of Vascular and Interventional Radiology·2025Open Access
FBLN1 regulates ferroptosis in acute respiratory distress syndrome by reducing free ferrous iron by inhibiting the TGF-β/Smad pathway
PLoS ONE·2024· 4 citedOpen Access
Validation of minimally invasive articular cartilage sparing technique for olecranon osteotomy
ANZ Journal of Surgery·2024Open Access
VIRAGE: A phase IIb, open-label, randomized study of nab-paclitaxel and gemcitabine plus/minus VCN-01 in patients with metastatic pancreatic cancer.
Journal of Clinical Oncology·2024· 2 cited
Sa2027 RAPID DETECTION OF KRAS MUTATIONS IN BILE FOR EARLY DIAGNOSIS OF MALIGNANCY
Gastroenterology·2024
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
Nature Medicine·2024· 73 citedOpen Access
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma
British Journal of Cancer·2023· 8 citedOpen Access
Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma
Investigational New Drugs·2023· 13 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Diane M. Simeone(6), Kent A. Griffith(5), Mark M. Zalupski(5), Vaibhav Sahai(4), Tanios Bekaii‐Saab(3), Stephen G. Young(3), Richard J. Bold(3), Mei‐Juan Tu(3), Ai‐Ming Yu(3), Hervé Tiriac(2), Tim D.D. Somerville(2), Richard A. Burkhart(2), Koji Miyabayashi(2), C. Megan Young(2), Jean L. Grem(2), Jonathan M. Buscaglia(2), Paul M. Grandgenett(2), Michael A. Hollingsworth(2), Christopher L. Wolfgang(2), Christopher R. Vakoc(2)